164 related articles for article (PubMed ID: 8082495)
1. Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Treem WR; Justinich CJ; Kreutzer DL
Dig Dis Sci; 1994 Sep; 39(9):1893-9. PubMed ID: 8082495
[TBL] [Abstract][Full Text] [Related]
2. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
3. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases.
Propst A; Propst T; Herold M; Vogel W; Judmaier G
Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1031-6. PubMed ID: 8680901
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
6. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
7. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
[TBL] [Abstract][Full Text] [Related]
8. Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).
Dionne S; D'Agata ID; Hiscott J; Vanounou T; Seidman EG
Clin Exp Immunol; 1998 Jun; 112(3):435-42. PubMed ID: 9649212
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
10. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
[TBL] [Abstract][Full Text] [Related]
11. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.
Kader HA; Tchernev VT; Satyaraj E; Lejnine S; Kotler G; Kingsmore SF; Patel DD
Am J Gastroenterol; 2005 Feb; 100(2):414-23. PubMed ID: 15667502
[TBL] [Abstract][Full Text] [Related]
12. Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1994 Jan; 35(1):77-83. PubMed ID: 8307455
[TBL] [Abstract][Full Text] [Related]
13. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
[TBL] [Abstract][Full Text] [Related]
14. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ
Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating levels of interleukin-1 receptor antagonist in patients with inflammatory bowel disease.
Kuboyama S
Kurume Med J; 1998; 45(1):33-7. PubMed ID: 9658748
[TBL] [Abstract][Full Text] [Related]
16. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.
Kiernan MG; Coffey JC; Sahebally SM; Tibbitts P; Lyons EM; O'leary E; Owolabi F; Dunne CP
J Crohns Colitis; 2020 Jan; 14(1):118-129. PubMed ID: 31241755
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
[TBL] [Abstract][Full Text] [Related]
19. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors.
Schaufelberger HD; Uhr MR; McGuckin C; Logan RP; Misiewicz JJ; Gordon-Smith EC; Beglinger C
Eur J Clin Invest; 1994 Oct; 24(10):656-63. PubMed ID: 7531643
[TBL] [Abstract][Full Text] [Related]
20. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study.
Hyams JS; Wyzga N; Kreutzer DL; Justinich CJ; Gronowicz GA
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):289-95. PubMed ID: 9138175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
